APA (7th ed.) Citation

Schardt, J. S., Walseng, E., Le, K., Yang, C., Shah, P., Fu, Y., . . . Mazor, Y. IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Schardt, John S., et al. IL-2-armored Peptide-major Histocompatibility Class I Bispecific Antibodies Redirect Antiviral Effector Memory CD8+ T Cells to Induce Potent Anti-cancer Cytotoxic Activity with Limited Cytokine Release. Taylor & Francis Group.

MLA (9th ed.) Citation

Schardt, John S., et al. IL-2-armored Peptide-major Histocompatibility Class I Bispecific Antibodies Redirect Antiviral Effector Memory CD8+ T Cells to Induce Potent Anti-cancer Cytotoxic Activity with Limited Cytokine Release. Taylor & Francis Group.